Suppr超能文献

基线 F-FDG PET/CT 参数在 MALT 淋巴瘤中的预后作用。

Prognostic role of baseline F-FDG PET/CT parameters in MALT lymphoma.

机构信息

Department of Nuclear Medicine, Spedali Civili di Brescia, Brescia, Italy.

Division of Hematology, Spedali Civili di Brescia, Brescia, Italy.

出版信息

Hematol Oncol. 2019 Feb;37(1):39-46. doi: 10.1002/hon.2563. Epub 2018 Nov 8.

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is an indolent lymphoma with good prognosis and variable fluorine-18 fluorodeoxyglucose ( F-FDG) avidity. Many possible prognostic factors have been investigated with controversial results, but the possible prognostic role of F-FDG positron emission tomography/computed tomography (PET/CT) remains unclear. Our aim was to evaluate the prognostic impact of qualitative and semiquantitative baseline PET/CT parameters on outcome of MALT lymphoma. We retrospectively enrolled 161 patients with histologically confirmed MALT lymphoma who underwent F-FDG PET/CT before any treatment. PET images were qualitatively and semiquantitatively analyzed by measuring the maximum standardized uptake value body weight (SUVbw), lean body mass (SUVlbm), body surface area (SUVbsa), metabolic tumor volume (MTV), and total lesion glycolysis (TLG). The Kaplan-Meier method was used to estimate the progression-free survival (PFS) and overall survival (OS) times. Cox regression models were performed to determine the relation between PET/CT features and OS and PFS. Ninety-eight patients had positive F-FDG PET/CT showing F-FDG uptake (mean SUVbw, 10.1; SUVlbm, 7.2; SUVbsa, 2.7; MTV, 88.8; and TLG, 526); the remaining 63 were not F-FDG avid. F-FDG avidity was significantly correlated with tumor size and Ki-67 score. Relapse/progression of disease occurred in 47 patients with an average time of 40.2 months; death occurred in 12 patients with an average of 59 months. At a median follow-up of 62 months, median PFS and OS were 52 and 62 months, respectively. Advanced tumor stage and extragastric site were demonstrated to be independent prognostic factors for PFS, while only tumor stage for OS. Instead, PET/CT parameters were not related to survival, despite positive correlation at univariate analysis between MTV and TLG with PFS and positive PET/CT with PFS and OS. In conclusion, a 61% rate of PET avidity in biopsy-confirmed MALT lymphoma was found, and it was correlated with tumor size and Ki-67 score. Only tumor stage and localization were independently correlated with PFS and OS.

摘要

黏膜相关淋巴组织(MALT)淋巴瘤是一种惰性淋巴瘤,预后良好,氟-18 氟代脱氧葡萄糖(F-FDG)摄取程度可变。已经研究了许多可能的预后因素,但 F-FDG 正电子发射断层扫描/计算机断层扫描(PET/CT)的可能预后作用仍不清楚。我们的目的是评估基线 PET/CT 定性和半定量参数对 MALT 淋巴瘤结局的预后影响。我们回顾性纳入了 161 例经组织学证实的 MALT 淋巴瘤患者,这些患者在任何治疗前均接受了 F-FDG PET/CT 检查。通过测量最大标准化摄取值(SUV)体重(SUVbw)、瘦体重(SUVlbm)、体表面积(SUVbsa)、代谢肿瘤体积(MTV)和总病灶糖酵解(TLG),对 PET 图像进行定性和半定量分析。采用 Kaplan-Meier 法估计无进展生存期(PFS)和总生存期(OS)。Cox 回归模型用于确定 PET/CT 特征与 OS 和 PFS 的关系。98 例患者的 F-FDG PET/CT 呈阳性,显示 F-FDG 摄取(平均 SUVbw 为 10.1,SUVlbm 为 7.2,SUVbsa 为 2.7,MTV 为 88.8,TLG 为 526);其余 63 例患者 F-FDG 摄取不活跃。F-FDG 摄取程度与肿瘤大小和 Ki-67 评分显著相关。47 例患者发生疾病复发/进展,平均时间为 40.2 个月;12 例患者死亡,平均时间为 59 个月。在中位随访 62 个月时,中位 PFS 和 OS 分别为 52 和 62 个月。晚期肿瘤分期和胃外部位被证明是 PFS 的独立预后因素,而仅肿瘤分期是 OS 的独立预后因素。然而,尽管 MTV 和 TLG 与 PFS、阳性 PET/CT 与 PFS 和 OS 呈单因素分析相关性,但 PET/CT 参数与生存无关。总之,在经活检证实的 MALT 淋巴瘤中,61%的患者 F-FDG 摄取呈阳性,且与肿瘤大小和 Ki-67 评分相关。只有肿瘤分期和定位与 PFS 和 OS 独立相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验